Literature DB >> 7047568

Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid.

N Cashman, C Martin, J F Eizenbaum, J D Degos, M A Bach.   

Abstract

To determine if previously reported peripheral blood suppressor cell defects are also found in the central nervous system (CNS) of patients with multiple sclerosis (MS), we studied cerebrospinal fluid (CSF) and peripheral blood lymphocytes from 40 MS patients and 15 patients with other neurological diseases. With an indirect immunofluorescence technique using the OKT series of monoclonal antibodies (OKT4, marking helper/inducer cells, OKT5 and OKT8 marking suppressor/cytotoxic cells, and OKT3 marking all peripheral T cells) we found that MS patients tested in the first 2 wk of exacerbation had invariably diminished CSF suppressor/cytotoxic cells, which was followed by an elevation of these cells in the 3rd wk of exacerbation. Repeat studies of three patients showed that perturbations of CSF suppressor/cytotoxic cells were dependent on clinical status. These observations add to the accumulating data that suggest altered immunity in the pathogenesis of MS.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7047568      PMCID: PMC371247          DOI: 10.1172/jci110628

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Letter: T and B lymphocytes in normal cerebrospinal fluid.

Authors:  P E Manconi; D Zaccheo; O Bugiani; M F Fadda; V Grifoni; G Mantovani; G S Del Giacco; S Tognella
Journal:  N Engl J Med       Date:  1976-01-01       Impact factor: 91.245

2.  Imbalances in T cell subpopulations in multiple sclerosis patients.

Authors:  D Santoli; L Moretta; R Lisak; D Gilden; H Koprowski
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

3.  B and T lymphocytes in cerebrospinal fluid and blood in multiple sclerosis, optic neuritis and mumps meningitis.

Authors:  S Kam-Hansen; A Frydén; H Link
Journal:  Acta Neurol Scand       Date:  1978-08       Impact factor: 3.209

4.  Suppressor cell function in multiple sclerosis.

Authors:  B G Arnason; J Antel
Journal:  Ann Immunol (Paris)       Date:  1978 Feb-Mar

5.  Demonstration of T lymphocytes in cerebrospinal fluid.

Authors:  A Naess
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

6.  Suppressor cell function in multiple sclerosis: correlation with clinical disease activity.

Authors:  J P Antel; B G Arnason; M E Medof
Journal:  Ann Neurol       Date:  1979-04       Impact factor: 10.422

7.  Altered regulation of mitogen responsiveness by suppressor cells in multiple sclerosis.

Authors:  R L Gonzalez; P C Dau; L E Spitler
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

8.  Tissue culture studies of demyelinating disease: a critical review.

Authors:  F J Seil
Journal:  Ann Neurol       Date:  1977-10       Impact factor: 10.422

9.  Quantitative studies of the inflammatory process in fatal viral meningoencephalitis.

Authors:  P C Doherty
Journal:  Am J Pathol       Date:  1973-12       Impact factor: 4.307

10.  Cytotoxic thymus-derived lymphocytes in cerebrospinal fluid of mice with lymphocytic choriomeningitis.

Authors:  R M Zinkernagel; P C Doherty
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  18 in total

1.  Cell count and ratio of helper/inducer to suppressor/cytotoxic T-cells in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  H W Kölmel; C Sudau
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

2.  Dual labelling of circulating CD8 cells in patients with multiple sclerosis.

Authors:  P J Hughes; P F Kirk; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

3.  Cerebrospinal fluid and peripheral blood T-lymphocyte subsets in multiple sclerosis: monoclonal antibody analysis and correlations with clinical activity.

Authors:  A Salmaggi; G Bianchi; D Cerrato; M Lazzaroni; L Malesani; A Nespolo; F Corridori; L La Mantia; C Milanese
Journal:  Ital J Neurol Sci       Date:  1987-08

4.  Regulation of interleukin 2 receptors on T cells from multiple sclerosis patients.

Authors:  E C DeFreitas; M Sandberg-Wollheim; K Schonely; M Boufal; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

5.  Suppressor T cell changes in active multiple sclerosis: analysis with three different monoclonal antibodies.

Authors:  A J Thompson; J Brazil; E A Martin; M Hutchinson; C A Whelan; C Feighery
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-10       Impact factor: 10.154

Review 6.  The role of prostaglandins in altered leukocyte function in multiple sclerosis.

Authors:  P Dore-Duffy; S Y Ho; M Longo
Journal:  Springer Semin Immunopathol       Date:  1985

7.  Cerebrospinal fluid lymphocyte subpopulations in multiple sclerosis.

Authors:  M G Marrosu; C Cianchetti; M G Ennas
Journal:  Ital J Neurol Sci       Date:  1986-02

Review 8.  Immunoregulatory T cells in multiple sclerosis: markers and functions.

Authors:  M A Bach
Journal:  Springer Semin Immunopathol       Date:  1985

9.  CD4+ lymphocyte subsets in the cerebrospinal fluid of multiple sclerosis and non-inflammatory neurological diseases.

Authors:  M Zaffaroni; L Gallo; A Ghezzi; C L Cazzullo
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

10.  Spinal fluid lymphocytes responsive to autologous and allogeneic cells in multiple sclerosis and control individuals.

Authors:  G Birnbaum; L Kotilinek; M Schwartz; M Sternad
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.